KK
Kuldeep Kanaiyalal Ribadiya
About Kuldeep Kanaiyalal Ribadiya
Data last updated:
Kuldeep Kanaiyalal Ribadiya is a Director at Symbiosis Bioscience Private Limited (since 2023) and Director at Axter Pharmaceuticals Private Limited (since 2015). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.55 Cr; the largest is Symbiosis Bioscience Private Limited at ₹4.13 Cr (FY 2025). Earlier, Kuldeep Kanaiyalal Ribadiya was a Director at Laxter Pharmaceuticals Private Limited (2019–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Oct 2023 | 2022 | ₹4.13 Cr (FY 2025) | Active | |
| Director | 30 Jul 2015 | 2014 | ₹3.43 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 May 2019 | 2018 | ₹1.51 Cr (FY 2023) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kuldeep Kanaiyalal Ribadiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagdish Pravinbhai Hirani | 06919912 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited | Director |
| Rushikumarkanaiyalal Ribadiya | 06919976 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited | Director |
| Sagar Pravinbhai Hirani | 06919987 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited | Director |
| Sakshi Laller | 10163397 | Symbiosis Bioscience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kuldeep Kanaiyalal Ribadiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kuldeep Kanaiyalal Ribadiya
Kuldeep Kanaiyalal Ribadiya currently holds 2 directorships: Symbiosis Bioscience Private Limited (Director, since 17 Oct 2023, revenue ₹4.13 Cr (FY 2025)); Axter Pharmaceuticals Private Limited (Director, since 30 Jul 2015, revenue ₹3.43 Cr (FY 2025)).
Kuldeep Kanaiyalal Ribadiya was first appointed on 30 Jul 2015 as Director at Axter Pharmaceuticals Private Limited. The most recent appointment on record is 17 Oct 2023 at Symbiosis Bioscience Private Limited.
The 2 current companies of Kuldeep Kanaiyalal Ribadiya that report revenue have a combined latest revenue of ₹7.55 Cr: Symbiosis Bioscience Private Limited ₹4.13 Cr (FY 2025); Axter Pharmaceuticals Private Limited ₹3.43 Cr (FY 2025).
Kuldeep Kanaiyalal Ribadiya held 1 earlier board appointment: Laxter Pharmaceuticals Private Limited (Director, 09 May 2019 to 22 Jan 2021).
The current boards of Kuldeep Kanaiyalal Ribadiya's companies include Jagdish Pravinbhai Hirani (Symbiosis Bioscience Private Limited), Rushikumarkanaiyalal Ribadiya (Symbiosis Bioscience Private Limited), Sagar Pravinbhai Hirani (Symbiosis Bioscience Private Limited), Sakshi Laller (Symbiosis Bioscience Private Limited).